# Codiak BioSciences, Inc.

Codiak BioSciences, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Codiak BioSciences, Inc.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001659352

## About

Codiak BioSciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001659352, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-03-10, it reported annual revenue of USD 22,935,000; net income of USD -37,157,000; total assets of USD 171,670,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $22.9M (USD 22,935,000)
- **Net income:** -$37.2M (USD -37,157,000)
- **Total assets:** $171.7M (USD 171,670,000)
- **Cash and equivalents:** $76.9M (USD 76,938,000)
- **Operating cash flow:** -$74.1M (USD -74,144,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $2.9M (USD 2,915,000)
- **Net income:** -$91.7M (USD -91,665,000)
- **Total assets:** $151.3M (USD 151,341,000)
- **Cash and equivalents:** $88.9M (USD 88,915,000)
- **Operating cash flow:** -$63.4M (USD -63,361,000)

## Recent SEC filings

- Form 8-K — filed 2023-03-29 — period 2023-03-27 — 8-K
- Form 8-K — filed 2023-03-27 — period 2023-03-23 — 8-K
- Form SC 13G — filed 2023-02-14
- Form SC 13G — filed 2023-02-08
- Form 10-Q — filed 2022-11-03 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-11-03 — period 2022-11-03 — 8-K
- Form SC 13D — filed 2022-09-20 — ARCH VENTURE FUND VIII, L.P. -- CODIAK BIOSCIENCES, INC. -- SCHEDULE 13D
- Form 8-K — filed 2022-09-14 — period 2022-09-12 — 8-K
- Form 8-K — filed 2022-08-30 — period 2022-08-25 — 8-K
- Form 10-Q — filed 2022-08-04 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-04 — period 2022-08-04 — 8-K
- Form 8-K — filed 2022-06-30 — period 2022-06-30 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/codiak-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology